| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |